|
Market Closed -
Bombay S.E.
14:03:02 11/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 138.95 INR | +1.68% |
|
+10.67% | +93.28% |
| 08-08 | ZIM Laboratories Limited, Q1 2027 Earnings Call, Aug 07, 2026 | |
| 08-06 | ZIM Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 7.44B 77.88M 67.1M 63.54M 57.59M 108M 109M 755M 290M 3.79B 292M 286M 11.96B | P/E 2025 |
32.1x | P/E 2026 | 50.3x |
|---|---|---|---|---|---|
| Enterprise Value | 8.3B 86.92M 74.89M 70.91M 64.27M 121M 121M 842M 324M 4.22B 326M 319M 13.35B | EV / Sales 2025 |
1.34x | EV / Sales 2026 | 1.09x |
| Free-Float |
28.77% | Yield 2025 * |
-
| Yield 2026 | - |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| ZIMLAB | Delayed | |
NSE India S.E.
| ZIMLAB | End-of-day quote |
Last Transcript: ZIM Laboratories Limited
| 1 day | +1.68% | ||
| 1 week | +10.67% | ||
| Current month | +12.37% | ||
| 1 month | +27.19% | ||
| 3 months | +23.02% | ||
| 6 months | +108.35% | ||
| Current year | +93.28% |
| 1 week | 126.25 | 144.85 | |
| 1 month | 108.45 | 144.85 | |
| Current year | 59.72 | 144.85 | |
| 1 year | 59.72 | 144.85 | |
| 3 years | 59.72 | 144.85 | |
| 5 years | 36.37 | 151.75 | |
| 10 years | 14 | 151.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CEO | Chief Executive Officer | - | 01/01/2002 |
| Director of Finance/CFO | - | 01/04/2019 | |
| Director of Finance/CFO | - | 01/01/1991 |
| Director | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CHM | Chairman | - | 01/01/1990 |
| Director/Board Member | - | 01/01/1991 | |
Prakash Sapkal
BRD | Director/Board Member | - | 01/01/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.68% | +10.67% | +82.97% | +17.60% | 77.88M | ||
| -1.13% | -3.11% | +13.82% | +60.17% | 46.21B | ||
| -0.62% | -3.96% | +32.92% | +106.77% | 38.78B | ||
| +0.12% | -0.08% | +7.12% | +73.98% | 11.68B | ||
| -0.53% | -1.37% | -13.25% | +11.19% | 11.55B | ||
| -0.38% | -2.26% | +18.18% | +142.99% | 9.14B | ||
| +0.16% | -1.49% | +23.47% | +35.50% | 7.3B | ||
| +0.17% | -0.74% | +13.44% | +180.68% | 7.15B | ||
| +0.75% | -3.35% | +34.11% | -19.22% | 7.1B | ||
| -3.13% | -4.30% | -44.88% | +12.88% | 4.97B | ||
| Average | -0.30% | -1.27% | +16.79% | +62.26% | 14.39B | |
| Weighted average by Cap. | -0.64% | -3.26% | +16.01% | +74.33% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.79B 39.69M 34.19M 32.38M 29.35M 55.05M 55.33M 385M 148M 1.93B 149M 146M 6.09B | 3.74B 39.19M 33.77M 31.97M 28.98M 54.37M 54.64M 380M 146M 1.9B 147M 144M 6.02B |
| Net income | 122M 1.27M 1.1M 1.04M 942K 1.77M 1.78M 12.34M 4.74M 61.89M 4.78M 4.68M 196M | 58.38M 611K 527K 499K 452K 848K 852K 5.92M 2.28M 29.7M 2.3M 2.24M 93.85M |
| Net Debt | 1.16B 12.12M 10.44M 9.89M 8.96M 16.81M 16.9M 117M 45.15M 589M 45.51M 44.51M 1.86B | 863M 9.03M 7.78M 7.37M 6.68M 12.53M 12.6M 87.53M 33.66M 439M 33.93M 33.18M 1.39B |
Employees
632
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | ₹138.95 | +1.68% | 9,466 |
| 10/09/26 | ₹136.65 | +2.78% | 17,475 |
| 09/09/26 | ₹132.95 | +2.94% | 7,870 |
| 08/09/26 | ₹129.15 | 0.00% | 1,834 |
| 07/09/26 | ₹129.15 | +2.87% | 7,712 |
- Stock Market
- Stocks
- ZIMLAB Stock
Select your edition
All financial news and data tailored to specific country editions

















